Pulse Biosciences, Inc (PLSE)
PLSE moved a median of +0.18% 30 minutes after news, and +0.66% by the close. How PLSE actually reacts to news — the realized, point-in-time move the market made, measured across 320 labeled events over the last three years with zero look-ahead.
PLSE’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | +0.05% | 51% | 317 |
| 30-min | +0.18% | 55% | 318 |
| 60-min | +0.25% | 58% | 318 |
| to close | +0.66% | 56% | 314 |
| Middle 50% of PLSE reactions | -1.30% to +1.98% |
|---|---|
| Median reaction (30-min) | +0.18% |
| Measured reactions | 320 |
Half of all Pulse Biosciences, Inc news events land between -1.30% and +1.98% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How PLSE reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 13 | +0.83% | 54% | +0.72% |
| Coverage initiations | 14 | +0.58% | 64% | +4.51% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 2 further classes were observed with fewer than 10 measured events and are not published. See how PLSE ranks against every other measured name →
That’s how PLSE usually reacts — get an email when it moves on news →Email me when PLSE moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to PLSE's baseline. Nothing else.
Recent PLSE events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K PULSE BIOSCIENCES, INC. For: Oct 14 | SEC filing · Form 8-K | SEC EDGAR | +0.02% | -2.69% | |
| Pulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid Center | Press release | Business Wire | +0.02% | -2.69% | |
| Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Press release | Business Wire | +0.39% | -2.02% | |
| Pulse Biosciences’ nPulse™ Technology to be Featured at the 21st Annual International VT Symposium 2026 | Press release | Business Wire | -0.37% | +2.21% | |
| Form 8-K PULSE BIOSCIENCES, INC. For: Oct 07 | SEC filing · Form 8-K | SEC EDGAR | -0.39% | -0.04% | |
| Pulse Biosciences Achieves Enrollment Target in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation Treatment | Press release | Business Wire | -0.39% | -0.04% | |
| Form 8-K PULSE BIOSCIENCES, INC. For: Sep 14 | SEC filing · Form 8-K | SEC EDGAR | -1.85% | -5.59% | |
| Form 8-K PULSE BIOSCIENCES, INC. For: Sep 15 | SEC filing · Form 8-K | SEC EDGAR | +0.11% | +1.83% | |
| Pulse Biosciences Completes Enrollment in the PRECISE-BTN Clinical Study Evaluating the nPulse™ Vybrance™ Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules | Press release | Business Wire | +0.11% | +1.83% | |
| Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Press release | Business Wire | -0.57% | -0.82% | |
| Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Press release | Business Wire | +2.56% | -1.71% | |
| Form 10-Q PULSE BIOSCIENCES, INC. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +2.21% | +12.08% | |
| Form 8-K PULSE BIOSCIENCES, INC. For: Aug 06 | SEC filing · Form 8-K | SEC EDGAR | +2.21% | +12.08% | |
| Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results | Press release | Business Wire | +2.21% | +12.08% | |
| Pulse Biosciences to Present at Canaccord Genuity’s 46th Annual Growth Conference | Press release | Business Wire | -0.30% | -0.82% | |
| Form 8-K PULSE BIOSCIENCES, INC. For: Jul 29 | SEC filing · Form 8-K | SEC EDGAR | +5.19% | -1.81% | |
| Pulse Biosciences Surpasses Enrollment Midpoint in NANOPULSE-AF IDE Pivotal Study | Press release | Business Wire | +5.19% | -1.81% | |
| Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026 | Press release | Business Wire | +0.56% | +7.66% | |
| Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Press release | Business Wire | +1.32% | +3.56% | |
| Form 8-K PULSE BIOSCIENCES, INC. For: Jun 11 | SEC filing · Form 8-K | SEC EDGAR | -1.96% | +3.70% | |
| Form 8-K PULSE BIOSCIENCES, INC. For: Jun 10 | SEC filing · Form 8-K | SEC EDGAR | +1.84% | +1.96% | |
| Pulse Biosciences, Inc. Announces Planned Redemption of Warrants | Press release | Business Wire | +1.84% | +1.96% | |
| Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 | Press release | Business Wire | -1.59% | +0.94% | |
| Form 10-Q PULSE BIOSCIENCES, INC. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.50% | +13.01% | |
| ATM Equity Purchases by Pulse Biosciences’ Co-Chairmen Total Approximately $13.3 Million | Press release | Business Wire | +0.28% | +12.34% | |
| Form DEF 14A PULSE BIOSCIENCES, INC. For: Jun 11 | SEC filing · Form DEF | SEC EDGAR | +1.06% | -0.94% | |
| Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference | Press release | Business Wire | -1.88% | -3.00% | |
| Form 8-K PULSE BIOSCIENCES, INC. For: May 05 | SEC filing · Form 8-K | SEC EDGAR | -0.65% | +3.89% | |
| Form 8-K PULSE BIOSCIENCES, INC. For: May 04 | SEC filing · Form 8-K | SEC EDGAR | +0.63% | -2.25% | |
| Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results | Press release | Business Wire | +0.63% | -2.25% | |
| Form 10-K/A PULSE BIOSCIENCES, INC. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.33% | -2.25% | |
| Form 8-K PULSE BIOSCIENCES, INC. For: Apr 25 | SEC filing · Form 8-K | SEC EDGAR | +2.69% | -1.65% | |
| Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026 | Press release | Business Wire | +2.69% | -1.65% | |
| Pulse Biosciences’ nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting | Press release | Business Wire | -1.22% | +1.54% | |
| Pulse Biosciences to Host Analyst Event on April 25, 2026 | Press release | Business Wire | +2.11% | +9.86% | |
| Form 8-K PULSE BIOSCIENCES, INC. For: Apr 16 | SEC filing · Form 8-K | SEC EDGAR | -0.55% | +3.01% | |
| Form 8-K PULSE BIOSCIENCES, INC. For: Apr 08 | SEC filing · Form 8-K | SEC EDGAR | -0.16% | +2.83% | |
| Pulse Biosciences Strengthens Executive Leadership Team | Press release | Business Wire | -0.16% | +2.83% | |
| Form 8-K PULSE BIOSCIENCES, INC. For: Apr 07 | SEC filing · Form 8-K | SEC EDGAR | -0.49% | +2.49% | |
| Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation | Press release | Business Wire | -2.22% | -11.29% | |
| Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference | Press release | Business Wire | +1.17% | -0.35% | |
| Form 8-K PULSE BIOSCIENCES, INC. For: Mar 23 | SEC filing · Form 8-K | SEC EDGAR | -2.09% | -4.71% | |
| Form 8-K PULSE BIOSCIENCES, INC. For: Mar 17 | SEC filing · Form 8-K | SEC EDGAR | +0.74% | +0.81% | |
| Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data | Press release | Business Wire | +0.74% | +0.81% | |
| Form 8-K PULSE BIOSCIENCES, INC. For: Mar 12 | SEC filing · Form 8-K | SEC EDGAR | -1.73% | +8.40% | |
| Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology | Press release | Business Wire | -1.73% | +8.40% | |
| Form 8-K PULSE BIOSCIENCES, INC. For: Mar 06 | SEC filing · Form 8-K | SEC EDGAR | +0.72% | +0.74% | |
| Pulse Biosciences Announces Clinical Data From nPulse™ Vybrance™ System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation | Press release | Business Wire | -0.22% | +0.52% | |
| Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference | Press release | Business Wire | +2.55% | +4.03% | |
| Pulse Biosciences’ nPulse™ Vybrance™ System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting | Press release | Business Wire | +0.60% | -0.71% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the PLSE section they belong to.
Where else PLSE is measured.
PLSE earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | 321 | -0.94% | 31% |
| Wave Life Sciences, Inc. (WVE) | 321 | -0.14% | 45% |
| Voyager Therapeutics, Inc. (VYGR) | 320 | -0.12% | 42% |
| Viking Therapeutics, Inc. (VKTX) | 319 | -0.60% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Pulse Biosciences, Inc's median reaction calculated?
Every labeled PLSE news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 320 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 55% of PLSE's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does PLSE's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.